Verition Fund Management’s GoHealth GOCO Stock Holding History

Verition Fund Management’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,742	Closed	-$9K	–	2370
2022 Q3	$9K	Hold	1,742	–	–	﹤0.01%	2875
2022 Q2	$16K	Buy	+1,742	New	+$20.3K	﹤0.01%	2233

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

GCM

Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Verition Fund Management's GOCO Position: Q4 2022 in Review

Verition Fund Management sold out of GoHealth (GOCO) in Q4 2022, closing a stake of 1,742 shares — an estimated $9K sold.

Verition Fund Management first reported a position in GOCO in Q2 2022 and held it in 2 quarters. The position peaked at $16K in Q2 2022. 35 funds tracked by Wall St. Rank hold GOCO as of Q4 2022.

Verition Fund Management reported no remaining GoHealth position as of Q4 2022 after selling out during the quarter.
Verition Fund Management sold 1,742 GoHealth shares in Q4 2022, an estimated $9K.
Verition Fund Management first reported a position in GoHealth in Q2 2022 and held it in 2 quarters.
Verition Fund Management's GoHealth position peaked at $16K in Q2 2022.
35 funds tracked by Wall St. Rank held GoHealth as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.